Spineguard (ALSGD) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.172x

Based on the latest financial reports, Spineguard (ALSGD) has a cash flow conversion efficiency ratio of -0.172x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-738.46K ≈ $-863.33K USD) by net assets (€4.28 Million ≈ $5.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Spineguard defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Spineguard - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Spineguard's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Spineguard Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Spineguard ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
ECP Emerging Growth Ltd AU:ECP	-0.023x
Capital Gearing Trust LSE:CGT	0.006x
Meta Epsi Tbk PT JK:MTPS	0.244x
CalciMedica, Inc. Common Stock NASDAQ:CALC	0.731x
Revenue Group Bhd KLSE:0200	0.178x
Cabnet Holdings Bhd KLSE:0191	0.009x
Cahayaputra Asa Keramik Tbk PT JK:CAKK	0.138x
Oakley Capital Investments Limited LSE:OCI	-0.052x

Annual Cash Flow Conversion Efficiency for Spineguard (2011–2024)

The table below shows the annual cash flow conversion efficiency of Spineguard from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Spineguard stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€3.90 Million ≈ $4.56 Million	€-2.35 Million ≈ $-2.74 Million	-0.601x	+0.63%
2023-12-31	€6.03 Million ≈ $7.05 Million	€-3.65 Million ≈ $-4.27 Million	-0.605x	-74.67%
2022-12-31	€5.14 Million ≈ $6.01 Million	€-1.78 Million ≈ $-2.08 Million	-0.346x	-51.31%
2021-12-31	€5.05 Million ≈ $5.90 Million	€-1.16 Million ≈ $-1.35 Million	-0.229x	-100.22%
2020-12-31	€-8.93K ≈ $-10.44K	€-948.67K ≈ $-1.11 Million	106.257x	+27931.10%
2019-12-31	€592.03K ≈ $692.15K	€224.42K ≈ $262.37K	0.379x	-72.27%
2018-12-31	€-489.56K ≈ $-572.35K	€-669.26K ≈ $-782.44K	1.367x	-88.66%
2017-12-31	€-208.50K ≈ $-243.75K	€-2.51 Million ≈ $-2.94 Million	12.051x	+455.49%
2016-12-31	€1.19 Million ≈ $1.39 Million	€-4.03 Million ≈ $-4.72 Million	-3.390x	-518.39%
2015-12-31	€4.73 Million ≈ $5.54 Million	€-2.60 Million ≈ $-3.03 Million	-0.548x	+4.69%
2014-12-31	€5.77 Million ≈ $6.74 Million	€-3.32 Million ≈ $-3.88 Million	-0.575x	-71.23%
2013-12-31	€8.92 Million ≈ $10.42 Million	€-2.99 Million ≈ $-3.50 Million	-0.336x	+39.27%
2012-12-31	€5.32 Million ≈ $6.22 Million	€-2.94 Million ≈ $-3.44 Million	-0.553x	-106.39%
2011-12-31	€7.15 Million ≈ $8.36 Million	€-1.92 Million ≈ $-2.24 Million	-0.268x	--

About Spineguard

PA:ALSGD France Medical Devices

Market Cap

$9.88 Million

€8.45 Million EUR

Market Cap Rank

#27069 Global

#468 in France

Share Price

€0.09

Change (1 day)

+1.24%

52-Week Range

€0.08 - €0.19

All Time High

€5.18